Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
By
MedTech Outlook | Friday, February 28, 2020
IVD technology is evolving faster with each passing day in the healthcare industry. How is it helping the healthcare industry?
FREMONT, CA: Today’s industry trends are deeply rooted in quick disease recognization, ease of use, and customized care for patients and the advanced use of analytics. They are facilitating the medical device manufacturers to extend the present base of IVD technologies and to pursue work on creating new ones. The technologies that are immensely influenced by these trends include liquid biopsy, artificial intelligence (AI), and molecular diagnostics, and the Internet of Things (IoT) used in combination with in-vitro diagnostics.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Liquid Biopsy
Liquid biopsy holds the potential to detect disease biomarkers in biological fluids, like blood or cerebrospinal fluid. As many patients prefer to prevent the pain of having cells or tissue removed for the lab analysis, this emerging IVD technology has attracted significant attention from the healthcare industry. Until now, liquid biopsy has proven to be very impactful in the identification of non-small cell lung and pancreatic cancer amongst a few others. Its enhancement in sensitivity and specificity levels demonstrates its promise for early detection of cancer and its other types.
IoT and AI in support of IVD technologies
Both AI and IoT have been integrated into in vitro diagnostics technology. AI provides advanced data analytics and a reduction of errors to IVD devices. IoT technology supported by AI helps in remote monitoring and management of devices and device proficiency during downtime. Through their intelligent devices, patients are linked to the medical data allocated from in vitro diagnostic tests.
Molecular diagnostics
With patients’ increasing acceptance of more customized diagnostics and the enhanced turnaround time for DNA testing results, the technology used for assessing biomarkers in the genome and the proteome has shifted to the foreground in the past few years. From the recognition of infectious diseases to oncology to the predictions of immune function and which medicines are suitable for a given disease, molecular diagnostics has a broad array of applications.
IVD technology has been given a boost by both the continued advancement of molecular diagnostics and the connection to intelligent devices at the intersection of IoT and AI. Apart from these trends, medical device manufacturers are expecting extra opportunities to develop more innovative products in the industry.
See Also: Top Genomics Solution Companies
More in News
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

However, if you would like to share the information in this article, you may use the link below:
www.medicaltechoutlook.com/news/3-key-in-vitro-diagnostic-testing-technologies-nwid-1080.html
